Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy. - sprookjes - yvandenbroek - TriplyDB

Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy.

Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy.

http://www.wikidata.org/entity/Q38175408

about

Arterial Hypertension Is Characterized by Imbalance of Pro-Angiogenic versus Anti-Angiogenic Factors Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio Inhibitory effect of curcumin on angiogenesis in a streptozotocin-induced diabetic rat model: An aortic ring assay.Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase.High Concentrations of Uric Acid Inhibit Endothelial Cell Migration via miR-663 Which Regulates Phosphatase and Tensin Homolog by Targeting Transforming Growth Factor-β1.Antiangiogenic Therapy for Diabetic Nephropathy.Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.Protective effects of adiponectin on uncoupling of glomerular VEGF-NO axis in early streptozotocin-induced type 2 diabetic rats.

P2860

Q35581401-4BD4AD6E-89D7-41EB-A54A-7CFEE7AC574F Q36741916-DA38F526-C7AD-44BB-B894-574E086C6B3A Q37346202-75FC7017-6329-4E5C-922D-F2F093F9CCA5 Q38283016-797D1073-3D62-4ED3-84F0-8485912AECC0 Q38897860-67E36E93-998F-4AEB-93F4-4C57701AA8B0 Q41403094-A52CA9D2-0256-4EBA-A15B-BD86C9A4DED2 Q51280486-C3FE3370-66C5-4E3E-9620-2334B4AEDF38 Q53027939-0818D0E8-322E-47C1-9093-6B4A59C2243C

P2860

Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy.

http://www.wikidata.org/entity/Q38175408

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Uncoupling of VEGF with endoth ...... s in the diabetic nephropathy.

@en

type

label

Uncoupling of VEGF with endoth ...... s in the diabetic nephropathy.

@en

prefLabel

Uncoupling of VEGF with endoth ...... s in the diabetic nephropathy.

@en

P1433

Q38175408-5BDA6C23-2A07-4F1A-89BD-304AB2D38DAA

P1476

Q38175408-EC39FA8A-A052-4427-9A22-F51C0EF1DAD4

P2093

Q38175408-0BD0BE0A-BDE9-4B8C-B6E8-740FAC4A1E6B

Q38175408-23D40EA4-948D-4906-B99D-767A6108153C

Q38175408-BAF38793-43B4-45F7-B81D-DD046B159FE2

Q38175408-F20DB612-9337-460A-8A65-5D3F63D59424

P275

Q38175408-47FEE8F5-BC21-4883-97D2-40ED72F311C6

P2860

Q38175408-04796711-64D0-4D08-AF8E-4A24C0E90A8D

Q38175408-09E07291-8DFF-4524-8C39-AB363F791F98

Q38175408-0AAD5033-CF6E-4578-B185-54D953D615CD

Q38175408-28EEDE0A-C0B5-4C11-96D8-15FAA52B6834

Q38175408-2A9248A2-C543-46D6-B2A9-27B62E4A3CDF

Q38175408-365A1817-59AF-4390-BD70-B5869AA96B27

Q38175408-3E675865-0FD6-4D44-A68A-2F844605AADB

Q38175408-4D311FD7-F091-40C6-AA43-A29464B3958F

Q38175408-58680AFA-A33A-4937-B70E-D16C1B77260F

Q38175408-60EF8BAE-4F96-4788-8337-2E9135B0DD58

P304

Q38175408-4B94F60F-0F87-4914-8CE5-8AD6EE1ECE42

P31

Q38175408-1EB3C7EC-1CA6-4846-A7EC-9D84B08D12E0

Q38175408-BE45D52B-A467-47BA-AE94-39004BAA9264

P356

Q38175408-4B9131A2-6D08-4A1A-B117-44603CB96018

P478

Q38175408-D087E167-9514-4326-A1B3-7E5B25DC8DF0

P577

Q38175408-C06BEC1C-BF9F-41B4-B6C7-D171D8D9F629

P5875

Q38175408-0C8BD5E9-71BF-4E2A-A5F1-597A3B91542E

P698

Q38175408-F76EB76E-853B-436B-ADB8-1DF1C2583B1A

P921

Q38175408-57C467C4-0993-4F4C-B53A-584E104E8C92

Q38175408-8EAD9514-689B-401A-9913-4CD0F79D0DEA

Q38175408-A2121CEF-B851-4C66-A749-F011C321A00C

Q38175408-F1E74AFB-F0AE-4D30-A0EF-E8D2A13CB55C

Q38175408-FB94388E-02F6-4EA2-A60B-4AFC3BA42641

P932

Q38175408-C75A9212-1F4E-45F4-8AF4-196B7D173C45

P356

P1433

Journal of Diabetes Research

P1476

Uncoupling of VEGF with endoth ...... s in the diabetic nephropathy.

@en

P2093

Richard J Johnson

http://www.w3.org/2001/XMLSchema#string

Takahiko Nakagawa

http://www.w3.org/2001/XMLSchema#string

Tomoki Kosugi

http://www.w3.org/2001/XMLSchema#string

Waichi Sato

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

VEGF(165) mediates glomerular endothelial repair

Vascular endothelial growth factor receptor-2-mediated mitogenesis is negatively regulated by vascular endothelial growth factor receptor-1 in tumor epithelial cells

Structural changes in renal arterioles in Type I diabetic patients.

Glucose scavenging of nitric oxide.

Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss.

eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists.

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.

Increased plasma concentration of von Willebrand factor in insulin dependent diabetics with incipient nephropathy.

Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse.

Vegfa protects the glomerular microvasculature in diabetes.

P304

184539

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/184539

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259567997

http://www.w3.org/2001/XMLSchema#string

P698

24386643

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

inorganic compound

P932

3872226

http://www.w3.org/2001/XMLSchema#string